MustGrow Biologics Corp.
MGROF
$0.7884
-$0.0325-3.96%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -91.64% | -- | 346,260.00% | 88,710.26% | 69,172.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -91.64% | -- | 346,260.00% | 88,710.26% | 69,172.00% |
| Cost of Revenue | -19.45% | -18.26% | -25.34% | 44.19% | 23.12% |
| Gross Profit | -98.12% | 1,616.64% | 1,483.99% | 1,754.03% | 1,501.94% |
| SG&A Expenses | 2.14% | 2.73% | -9.91% | -19.17% | -20.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.83% | -0.30% | -12.30% | -12.03% | -9.74% |
| Operating Income | -1,656.29% | 103.77% | 101.28% | 96.48% | 95.36% |
| Income Before Tax | -569.54% | 95.26% | 91.73% | 87.64% | 87.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -569.54% | 95.26% | 91.73% | 87.64% | 87.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -569.54% | 95.26% | 91.73% | 87.64% | 87.56% |
| EBIT | -1,656.29% | 103.77% | 101.28% | 96.48% | 95.36% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -512.39% | 96.99% | 92.41% | 87.72% | 87.07% |
| Normalized Basic EPS | -517.14% | 97.06% | 92.34% | 87.73% | 87.16% |
| EPS Diluted | -512.39% | 96.99% | 92.41% | 87.72% | 87.07% |
| Normalized Diluted EPS | -517.14% | 97.06% | 92.34% | 87.73% | 87.16% |
| Average Basic Shares Outstanding | 3.41% | 3.09% | 2.50% | 1.77% | 1.81% |
| Average Diluted Shares Outstanding | 3.41% | 3.09% | 2.50% | 1.77% | 1.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |